← Back to Search

Polyphenol

Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes?

Phase 4
Waitlist Available
Led By Shayne P Taback, MD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 3 months after intervention
Awards & highlights
Drug Has Already Been Approved
Pivotal Trial

Summary

This trial tests if resveratrol supplements can help post-partum women who had gestational diabetes by keeping their insulin-producing cells healthy and improving their body's use of insulin. Resveratrol has been studied for its potential benefits in improving insulin sensitivity and glycemic control in various populations, including those with type 2 diabetes and metabolic syndrome.

Eligible Conditions
  • Gestational Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 3 months after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 3 months after intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in beta cell function
Secondary study objectives
Change in insulin sensitivity
Other study objectives
change in liver function

Side effects data

From 2013 Phase 2 trial • 24 Patients • NCT02114892
25%
Headache
8%
Abdominal pain
8%
Sickness
100%
80%
60%
40%
20%
0%
Study treatment Arm
Resveratrol
Placebo

Awards & Highlights

Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ResveratrolExperimental Treatment1 Intervention
Resveratrol capsules, 250 mg twice a day for 3 months
Group II: PlaceboPlacebo Group1 Intervention
Corn starch capsules, 1 capsule twice a day for 3 months
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resveratrol
2014
Completed Phase 3
~730

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
621 Previous Clinical Trials
206,451 Total Patients Enrolled
Manitoba Institute of Child HealthIndustry Sponsor
8 Previous Clinical Trials
6,816 Total Patients Enrolled
Shayne P Taback, MDPrincipal InvestigatorUniversity of Manitoba
~10 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top